Depending on where you live, spring is here—or at least on its way. It’s the time of year to thaw out along with the trees, grass, and flowers. With spring comes our promise to get ourselves into shape for the summer, and life gets busier with more outdoor activities for the whole family.
On the surface, eyecare providers may not fully appreciate the prevalence and complexity of ocular allergy and its clinical management; we learn that it is a relatively simple disease defined by ocular itch.
A wearable skin patch (Viaskin, DBV Technologies) may help treat peanut allergy, specifically in children and young adults, according to one-year results of an ongoing trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the NIAID-funded Consortium of Food Allergy Research(CoFAR).
As technology leaps forward with medicine, it is prudent at times to appreciate how far we have come in managing and treating allergic eye disease. In fact, let us look back to the beginning in ancient Rome with the first recorded case of atopy. One of these authors, Suetonius, wrote with great detail in his biographical text De vita Caeserum about the distinctive lives of the first Roman emperors.
Although still underused among available diagnostic procedures, nasal cytology is viewed by many specialists as an indispensable adjunctive diagnostic exam that clinicians can and should use more often to optimally diagnose, treat, and manage the myriad of nasal disorders and diseases occurring in pediatric patients.
As optometry’s scope of practice has increased, optometrists have embraced allergic eye disease. Ocular allergies have multiple effects to patients in our practice. But, if allergies are unidentified because symptoms may not be present during office visits, patients may treat themselves.